They also found that inhibitors such as HOE642 (NHE1 inhibitor) or DPI (NOX inhibitor) significantly reduced ischemia‐mediated NOX activation and ROS formation in vitro, which could be a new neuroprotective strategy [163]. The gene discussed is SLC9A1; the disease is ischemia.